(Q38436799)

English

Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.

scientific article published on 04 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

hyperparathyroidism

1 reference

based on heuristic

inferred from title

secondary hyperparathyroidism

1 reference

based on heuristic

inferred from title

Mario Cozzolino

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Markus Ketteler

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Kevin J Martin

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Amit Sharma

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

David Goldsmith

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Samina Khan

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

0 references

publication date

4 February 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

899-905

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Histomorphometric measurements of bone turnover, mineralization, and volume

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Metabolic bone disease in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

FGF-23 and the progression of coronary arterial calcification in patients new to dialysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Impact of kidney bone disease and its management on survival of patients on dialysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU011

21 January 2018

Identifiers

10.1093/NDT/GFU011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

release_fulfkoiwuna55ipkiitkr37hdm

1 reference

https://api.fatcat.wiki/v0/release/fulfkoiwuna55ipkiitkr37hdm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38436799&oldid=1844479239"